Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Sesen (Vicineum) was disqualified on that

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon May 04, 2022 11:55am

230 Views

Post# 34655248

RE:Sesen (Vicineum) was disqualified on that

Quick question. I know biologic agents have different production challenges and concerns with safety and contamination in the manufacturing process.

Can we confirm that TLD-1433 has a more straightforward, non BLA production process? If so that probably reduces some of the Vicineum issues above around production. I think it does but thought I would confirm. More chance to satisfy FDA requirements in the long run.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments